nextgene- analysis software version 1.94 (SoftGenetics)
90
Structured Review
SoftGenetics
nextgene- analysis software version 1.94
Nextgene Analysis Software Version 1.94, supplied by SoftGenetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nextgene-+analysis+software+version+1%2E94/nextgene++analysis+software+version+1+94/pm21562039-55-6-11
Average 90 stars, based on 1 article reviews
Nextgene Analysis Software Version 1.94, supplied by SoftGenetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nextgene-+analysis+software+version+1%2E94/nextgene++analysis+software+version+1+94/pm21562039-55-6-11
Average 90 stars, based on 1 article reviews
nextgene- analysis software version 1.94 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Sequencing:Article Title: Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphoma. Article Snippet: 1Department of Medical Genetics, University of Helsinki, Helsinki, Finland; 2Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland; 3Department of Pathology, HUSLAB, Helsinki University Central Hospital and Haartman Institute, University of Helsinki, Helsinki, Finland; 4Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 5Department of Haematology, St Mary’s Hospital, Campus of Imperial College, London, United Kingdom; 6Service d’Hématologie, University Bordeaux Segalen, Bordeaux, France; 7Division of Hematology-Oncology, Faculty of Medicine, Erciyes University, Kayseri, Turkey; 8Section of Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 9Department of Pathology, Institute of Diagnostics, University of Oulu, Oulu, Finland; and 10Institute for Molecular Medicine Finland, Helsinki, Finland Software:Article Title: Exome sequencing reveals germline NPAT mutation as a candidate risk factor for Hodgkin lymphoma. Article Snippet: 1Department of Medical Genetics, University of Helsinki, Helsinki, Finland; 2Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland; 3Department of Pathology, HUSLAB, Helsinki University Central Hospital and Haartman Institute, University of Helsinki, Helsinki, Finland; 4Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom; 5Department of Haematology, St Mary’s Hospital, Campus of Imperial College, London, United Kingdom; 6Service d’Hématologie, University Bordeaux Segalen, Bordeaux, France; 7Division of Hematology-Oncology, Faculty of Medicine, Erciyes University, Kayseri, Turkey; 8Section of Epidemiology, Institute of Cancer Research, Sutton, United Kingdom; 9Department of Pathology, Institute of Diagnostics, University of Oulu, Oulu, Finland; and 10Institute for Molecular Medicine Finland, Helsinki, Finland |